Compare GGB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GGB | GKOS |
|---|---|---|
| Founded | 1901 | 1998 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.7B |
| IPO Year | 2000 | 2015 |
| Metric | GGB | GKOS |
|---|---|---|
| Price | $5.02 | $164.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $5.76 | ★ $199.31 |
| AVG Volume (30 Days) | ★ 11.9M | 927.3K |
| Earning Date | 10-26-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $507,442,000.00 |
| Revenue This Year | $1.24 | $36.30 |
| Revenue Next Year | $3.35 | $23.25 |
| P/E Ratio | $13.89 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $3.14 | $73.16 |
| 52 Week High | $5.48 | $191.62 |
| Indicator | GGB | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 48.63 |
| Support Level | $4.86 | $147.72 |
| Resistance Level | $5.18 | $186.99 |
| Average True Range (ATR) | 0.15 | 7.39 |
| MACD | 0.00 | 0.80 |
| Stochastic Oscillator | 44.71 | 64.90 |
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.